Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering
Electra Therapeutics priced an upsized initial public offering of 23,333,334 shares at $15.00 per share, with expected gross proceeds of approximately $350.0 million before underwriting discounts and expenses. Shares begin trading on the Nasdaq Global Select Market on September 18, 2026 under the ticker ETRA, with closing expected September 21; underwriters hold a 30-day option to purchase up to 3,500,000 additional shares at the offering price. Jefferies, TD Cowen, Evercore ISI and Cantor are acting as joint book-running managers for the offering.
Key figures
- Deal Value Usd
- 350000000
- Offering Price
- 15
- Shares Offered
- 23333334
- Exchange
- Nasdaq Global Select Market
- Expected closing date
- September 21, 2026
- Expected trading date
- September 18, 2026
- Over allotment shares
- 3500000
- Over allotment option days
- 30
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.